版本:
中国

BRIEF-Organovo introduces 3D bioprinted human liver as leading therapeutic tissue in preclinical development

Oct 5 Organovo Holdings :

* Intends to submit an investigational new drug application to U.S. FDA for its therapeutic liver tissue in three to five years

* Organovo introduces 3D bioprinted human liver as leading therapeutic tissue in preclinical development Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐